Fig. 3

Forest plots illustrating the relationship between POR genetic variants and tacrolimus pharmacokinetics. A C₀/Dose of POR*1/*1 carriers versus POR*28 carriers at different post-transplantation time courses; B C₀/Dose of POR*1/*1 carriers versus POR*28 carriers in CYP3A5 expressers at different post-transplantations time courses; C C₀/Dose of POR*1/*1 carriers versus POR*28 carriers in CYP3A5 non-expressers at different post-transplantations time courses; D C₀/Dose of POR*1/*1 carriers versus POR*28 carriers in Asian recipients at different post-transplantations time courses; E C₀/Dose of POR*1/*1 carriers versus POR*28 carriers in Caucasian recipients at different post-transplantations time courses